ArticlePharmaceuticals (Basel, Switzerland)2026

Xu Chunfu's Modified Xianglian Pill Regulates the NOX2/ROS/Mitochondria/NLRP3 Axis to Treat Ulcerative Colitis.

Shangling Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.